Everything below concerns Dual agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
==== Smoking ==== Dry leaves can be smoked in a pipe, or through the use of a water pipe to cool the smoke. The temperature required to release salvinorin from the plant material is quite high (about 240 °C). A cooler flame will work, but the direct application of a more intense flame, such as that of a torch lighter, is often preferred. Some find that untreated dry leaf produces unnoticeable or only light effects. Concentrated preparations or extracts which may be smoked in place of untreated leaves, have become widely available. This enhanced (or "fortified") leaf is described by a number followed by an x (e.g. 5x, 10x), the multiplicative factors being generally indicative of the relative amounts of leaf concentrate, though there is no accepted standard for these claims. Other sources may use a system of color codes to form their own standards of potency; for example, "green", "yellow", and "red." These grades of potency may be roughly indicative of the relative concentration of the active principle, (salvinorin A), but the measure should not be taken as absolute. Overall extract potency will depend on the (naturally varying) strength of the untreated leaf used in preparing the extract, as well as the efficiency of the extraction process itself. Extracts reduce the overall amount of inhalations needed to ingest a given amount of active principle, thus facilitating more powerful experiences. If salvia is smoked, then the main effects are experienced quickly.
=== Materials === Material selection is an essential aspect of producing a scaffold. The materials utilized can be natural or synthetic and can be biodegradable or non-biodegradable. Additionally, they must be biocompatible, meaning that they do not cause any adverse effects to cells. Silicone, for example, is a synthetic, non-biodegradable material commonly used as a drug delivery material, while gelatin is a biodegradable, natural material commonly used in cell-culture scaffolds The material needed for each application is different, and dependent on the desired mechanical properties of the material. Tissue engineering of long bone defects for example, will require a rigid scaffold with a compressive strength similar to that of cortical bone (100-150 MPa), which is much higher compared to a scaffold for skin regeneration. There are a few versatile synthetic materials used for many different scaffold applications. One commonly used materials is polylactic acid (PLA), a polyester which degrades within the human body to form lactic acid, a naturally occurring chemical which is easily removed from the body. Similar materials are polyglycolic acid (PGA) and polycaprolactone (PCL); their degradation mechanism is similar to that of PLA, but PCL degrades slower and PGA degrades faster. PLA is commonly combined with PGA to create poly-lactic-co-glycolic acid (PLGA). This is useful because the degradation of PLGA can be tailored by altering the weight percentages of PLA and PGA: More PLA – slower degradation, more PGA – faster degradation.
Iron–sulfur clusters occur in many biological systems, often as components of electron transfer proteins. The ferredoxin proteins are the most common Fe–S proteins in nature. They feature either 2Fe–2S or 4Fe–4S centers. They occur in all branches of life. Fe–S clusters can be classified according to their Fe:S stoichiometry [2Fe–2S], [4Fe–3S], [3Fe–4S], and [4Fe–4S]. The [4Fe–4S] clusters occur in two forms: normal ferredoxins and high potential iron proteins (HiPIP). Both adopt cuboidal structures, but they utilize different oxidation states. They are found in all forms of life. The relevant redox couple in all Fe–S proteins is Fe(II)/Fe(III). Many clusters have been synthesized in the laboratory with the formula [Fe4S4(SR)4]2−, which are known for many R substituents, and with many cations. Variations have been prepared including the incomplete cubanes [Fe3S4(SR)3]3−.
SWAPO leaders soon went abroad to mobilise support for their goals within the international community and newly independent African states in particular. The movement scored a major diplomatic success when it was recognised by Tanganyika and allowed to open an office in Dar es Salaam. SWAPO's first manifesto, released in July 1960, was remarkably similar to SWANU's. Both advocated the abolition of colonialism and all forms of racialism, the promotion of Pan-Africanism, and called for the "economic, social, and cultural advancement" of South West Africans. However, SWAPO went a step further by demanding immediate independence under black majority rule, to be granted at a date no later than 1963. The SWAPO manifesto also promised universal suffrage, sweeping welfare programmes, free healthcare, free public education, the nationalisation of all major industry, and the forcible redistribution of foreign-owned land "in accordance with African communal ownership principles". Compared to SWANU, SWAPO's potential for wielding political influence within South West Africa was limited, and it was accordingly likelier to accept armed insurrection as the primary means of achieving its goals. SWAPO leaders also argued that a decision to take up arms against the South Africans would demonstrate their superior commitment to the nationalist cause. They believed that this would distinguish SWAPO from SWANU in the eyes of international supporters as the genuine vanguard of the Namibian independence struggle, and the legitimate recipient of any material assistance that was forthcoming.
Sources: en.wikipedia.org
In MASS, the sample is spun at several kilohertz around an axis that makes the so-called magic angle θm (which is ~54.74°, where 3cos2θm-1 = 0) with respect to the direction of the static magnetic field B0; as a result of such magic angle sample spinning, the broad chemical shift anisotropy bands are averaged to their corresponding average (isotropic) chemical shift values. Correct alignment of the sample rotation axis as close as possible to θm is essential for cancelling out the chemical-shift anisotropy broadening. There are different angles for the sample spinning relative to the applied field for the averaging of electric quadrupole interactions and paramagnetic interactions, correspondingly ~30.6° and ~70.1°. In amorphous materials, residual line broadening remains since each segment is in a slightly different environment, therefore exhibiting a slightly different NMR frequency. Line broadening or splitting by dipolar or J-couplings to nearby 1H nuclei is usually removed by radio-frequency pulses applied at the 1H frequency during signal detection. The concept of cross polarization developed by Sven Hartmann and Erwin Hahn was utilized in transferring magnetization from protons to less sensitive nuclei by M.G. Gibby, Alex Pines and John S. Waugh. Then, Jake Schaefer and Ed Stejskal demonstrated the powerful use of cross polarization under MAS conditions (CP-MAS) and proton decoupling, which is now routinely employed to measure high-resolution spectra of low-abundance and low-sensitivity nuclei, such as carbon-13, silicon-29, or nitrogen-15, in solids.
=== Absorption === 2,6-DCBQ is mainly absorbed via the oral route, typically through the ingestion of contaminated drinking water. Dermal absorption is also considered a viable pathway following aqueous exposure. The compound's low molecular weight and moderate lipophilicity favor absorption across the gastrointestinal tract. However, the high reactivity may limit total systemic bioavailability. The quinone structure reacts rapidly with biological nucleophiles in physiological fluids, leading to localized interactions before the unchanged compound can reach systemic circulation.
=== Guest === Christian Kane as Jacob Stone, one of the Librarians from the Portland, Oregon Annex who specializes in archaeology, art history, and architecture. He was introduced in The Librarians. Arielle Dombasle as Dame Anna Mirinoff (season 1) Celyn Jones as Cupid, God of Love; Vikram's friend (season 1) Ike Bennett as Pedro Worth, a friend of Connor Green (season 1) Hannah Devlin as Hermione Palvis, a descendant of the ancient Greek Muses who can make art come alive (season 1) Philip Rosch as Sir Lancelot du Lac (season 1), Elaine's former lover and fellow ex-knight of Camelot, who became immortal along with her when they summoned the power of his shield during a battle in Medieval times. Matt Frewer played Lancelot living as a 21st-century man and using the name "Dulaque" in The Librarians, serving as the main antagonist of the first season, with Jerry O'Connell playing his younger self.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.